Characterization by Western Blotting of the lmmunogens of Infectious Bursal Disease Virus

Size: px
Start display at page:

Download "Characterization by Western Blotting of the lmmunogens of Infectious Bursal Disease Virus"

Transcription

1 J. gen. Virol. (1985), 66, Printed in Great Britain 1479 Key words: IB D virus/ immunogens/polypeptides Characterization by Western Blotting of the lmmunogens of Infectious Bursal Disease Virus By K. J. FAHEY,* I. J. O'DONNELL 1 AND A. A. AZAD 1 CSIRO Division of Animal Health, Animal Health Research Laboratory, Private Bag No. 1, Parkville, Victoria 3052 and 1CSIRO Division of Protein Chemistry, 343 Royal Parade, Parkville, Victoria 3052, Australia (Accepted 4 March 1985) SUMMARY The Australian isolate of infectious bursal disease (IBD) virus (002/73) was purified from infected bursae by rate-zonal and density-equilibrium centrifugation and characterized by polyacrylamide gel electrophoresis. Two major polypeptides having approximate mol. wt. of (32K) and 37K and three other polypeptides of approximate mol. wt. 29K, 41.5K and 91.5K were present in all preparations of virus having a buoyant density of 1.33 g/ml. Western blotting of the polypeptides of IBD virus showed that the initial antibody response of chickens infected with live virus or injected with an inactivated oil-emulsion vaccine was directed primarily towards the 32K polypeptide. Only sera obtained late in the response to live virus or following hyperimmunization contained antibodies recognizing the 29K, 37K and 41-5K polypeptides. An antibody response to the 91.5K polypeptide was not detected routinely by this technique. It was concluded that the 32K polypeptide is a major immunogen of IBD virus. INTRODUCTION Infectious bursal disease (IBD) virus causes a highly contagious immunodepressive disease of young chickens which is characterized by a marked necrosis of lymphoid cells in the bursa of Fabricius. Humoral antibody protects against infection, and maternal antibody transmitted to chickens via the egg yolk protects them through the critical first 4 to 5 weeks after hatching (Wyeth & Chettle, 1982). Injecting breeding hens, previously exposed to the live IBD virus, with an inactivated oil-emulsion whole virus vaccine prior to the point of lay has proved an important means of elevating the levels of maternal antibody to IBD virus in chickens and improving the performance of commercial flocks (Wyeth et al., 198 l). As a first step towards the development of a safe, inexpensive and effective subunit vaccine to control this economically important disease, it was necessary to identify the structural proteins of the virus which are immunogenic in chickens. Overseas isolates of IBD virus have been found to have four structural proteins with tool. wt. in the regions of (28K), 32K, 40K and 90K (Nick et al., 1976; Dobos, 1979; Todd & McNulty, 1979; Miiller & Becht, 1982) with a precursor protein of 47K to 49K being present in some preparations (Dobos, 1979; Miiller & Becht, 1982). The genome of IBD virus has been shown to consist of two segments ofdsrna with tool. wt. of 2.5 x 106 and 2.2 x 106 (Miiller et al., 1979). The present paper reports the purification for the first time of an Australian isolate of IBD virus and the characterization of its structural polypeptides. A direct comparison with exotic strains of this virus was not possible as these cannot be imported into Australia. The specificities of the antibodies produced during the primary responses of chickens to an experimental infection with IBD virus or the injection of a commercial inactivated whole virus vaccine were analysed by Western blotting, as were the specificities of the antibodies that arise following hyperimmunization SGM

2 1480 K.J. FAHEY, I. J. O'DONNELL AND A. A. AZAD METHODS Growth and purification oflbd virus. The isolate 002/73 of IBD virus was originally obtained in Australia by Firth (1974) from commercial poultry with varying degrees of bursitis and identified serologically as type 1 IBD virus at the Central Veterinary Laboratory, Weybridge, U.K. Following propagation at a limiting dilution of infectivity, the virus was routinely propagated by intraocular inoculation of 4- to 6-week-old specified pathogenfree (SPF) white Leghorn chickens (CSIRO SPF Poultry Unit, Maribyrnong, Victoria, Australia). Homogenates of infected bursae of Fabricius were prepared as 10% (w/v) suspensions in phosphate-buffered saline (PBS) and stored at -80 C. The IBD virus stocks appeared to be free of contamination by other poultry viruses on electron microscopic examination and did not cross-react in the agar gel precipitation test with antisera to avian reovirus. The virus was purified by a modification of the method of Todd & McNulty (1979). An equal weight of chilled PBS was added to the freshly harvested bursae which were homogenized in an ice bath by three 20 s bursts of a Polytron (PT-10-OD; K inematica, Luzern, Switzerland) on setting 5. The homogenate was frozen to -80 C and thawed rapidly before an equal volume of the fluorocarbon Arklone (Wertheim Laboratories, Melbourne, Australia) was added and the mixture rehomogenized. After centrifugation at g for 30 min at 5 C, the aqueous phase (approx. 7 ml) was collected and layered onto chilled 25 to 50% (w/v) sucrose gradients (20 ml) prepared in 0.1 M-NaCI, 0"01 M-Tris-HCI buffer ph 7-6 (NaCl-Tris buffer). After centrifugation at r.p.m. for 1.5 h in a Beckman SW28 rotor at 5 C, the gradients were harvested from the bottom in 1 ml fractions. These were then examined by gel electrophoresis, Western blotting with hyperimmune sera, ELISA and by an assay for dsrna in order to determine the position of complete or incomplete particles of virus and soluble proteins of the virus. (In later preparations the virus was collected from the interface of a step gradient prepared by overlaying 10 ml of 40% sucrose on 5 ml of 60% sucrose.) Fractions containing complete (intact) virus were pooled and layered onto chilled preformed 20% to 40% (w/v) CsCI gradients (10 ml) which were centrifuged at r.p.m, for l 8 h at 5 C in a Beckman SW40 Ti rotor and the band of IBD virus was harvested through the side of the tube. The virus was dialysed against NaCI-Tris buffer to remove CsC1 and then against NaCI-Tris buffer containing 0.05% (w/v) sodium azide before being stored at 4 C or else made 50% (v/v) in glycerol and stored at -20 C. Chicken antisera to IBD virus. SPF chickens were infected intraocularly with IBD virus and bled 0, 3, 5, 7, 10 and 14 days later, then every 2 weeks. Chickens injected intramuscularly with 0.5 ml of commercial inactivated oilemulsion vaccine (Arthur Webster Pty Ltd., Northmead, New South Wales, Australia) were bled fortnightly, as were chickens given a second intraocular infection with IBD virus and previously infected chickens given an intramuscular injection of commercial inactivated vaccine. The sera were collected by centrifugation at 400 g for 15 min and stored at -20 C. Enzyme-linked immunosorbent assay (EL1SA). The ELISA method used to assess the presence of IBD viral antigen in various gradient fractions or chicken antibody to IBD virus was essentially that described by York et al. (1983), except that the microtitre trays (Nunc Immunoplate I) were coated with rabbit anti-ibd virus IgG prepared by hyperimmunizing rabbits with 002/73. To titrate antibodies to IBD virus, dilutions of chicken sera were added to the wells that had first been coated with rabbit antibody followed by a standardized concentration of an extract of infected bursae. The amount of chicken antibody binding to the viral antigen in each assay was then quantified by adding sheep IgG anti-chicken IgG-horseradish peroxidase conjugate, followed by the substrate 5-aminosalicylic acid. To detect viral antigens in the gradient, dilutions of each of the fractions were added to the coated wells, which were then treated with a 1:500 dilution of chicken antiserum to IBD virus which was capable of producing a maximum A45o of 1-0 following the addition of the conjugated antiserum and substrate. The trays were shaken for 30 min and the Aa50 was then read immediately on a Titertek Multiskan (Flow Laboratories). Polyacrylamide gelelectrophoresis (PAGE) and Western blotting. Aliquots (40 p.l) of each sucrose gradient fraction were dried under vacuum, resuspended in 20 ~1 of the sample buffer described by Laemmli (1970) which contained SDS and a trace of bromophenol blue dye, then heated for 3 min in a boiling water-bath. These samples were examined by discontinuous PAGE (Laemmli, i970) with Coomassie Brilliant Blue staining. The structural proteins of the virus, separated by SDS-PAGE, were also examined by the Western blotting procedure described by Burnette (1981). The viral proteins were transferred to nitrocellulose membrane filters (Schleicher & Schiill, BA gm) and probed with chicken antisera diluted 1:500 in 1% (w/v) gelatin in NaC1-Tris buffer. The chicken antibodies binding to viral polypeptides were identified with rabbit IgG anti-chicken IgG (Cappel Laboratories) diluted 1 : 1000 in NaCl-Tris-gelatin buffer followed by 1 gci of 125i_Protei n A (Amersham) in the same buffer. An autoradiograph of the nitrocellulose membrane was prepared using Fuji Rx Medical X-ray film and Ilford Fast Tungstate intensifying screens for 16 to 24 h at -70 C. Detection of lbd virus by the RNA content of various fractions. Sucrose gradient fractions were diluted to 1 : 4 with 10 mm-tris-hc1, 50 mm-nac1, 0.2~ SDS buffer, ph 7.5 and treated with 0.5 mg/ml ribonuclease-free Pronase (Worthington) for 1 h at 37 C. The solutions were made 0.3 M with respect to NaC1 and the nucleic acids were extracted with phenol and chloroform then ethanol-precipitated (Azad et al., 1985). Samples of RNA were electrophoresed under n0n-denaturing conditions in 1% (w/v) agarose slab gels in 20 mm-phosphate buffer ph 6.8,

3 Immunogens of IBD virus 1481 together with 2 DNA standards (Boehringer). When the gels were stained with acridine orange and illuminated with u.v. light, the dsdna or dsrna appeared as green bands while ssrna appeared as red bands (McMaster & Carmichael, 1977). RESULTS Purification of IBD virus from infected bursae Following centrifugation of the clarified bursal homogenates in 25 to 50 ~ continuous sucrose gradients, a major band of material was visible approximately three-fifths of the way down the gradient. SDS-PAGE analysis of the gradient fractions indicated that the highest concentration of viral proteins was in the visible band, while fractions immediately above and below the major band contained lower amounts of the viral proteins. Similarly, the ELISA for viral antigen revealed peaks of IBD viral antigen throughout the gradient, although the visible band again contained the highest relative concentration. The electrophoretic profiles of total RNA from different sucrose gradient fractions located two segments of viral RNA in two regions of the gradient, one corresponding to the major visible band low in the gradient and the other near the top of the gradient. The colour reaction with acridine orange showed that the two viral RNA segments were double-stranded. Electron microscopic examination of the fractions revealed that complete virus particles were only present in the lower region of the gradient. When electrophoresed under non-denaturing conditions with 2 dsdna as standards, the two viral RNA segments appeared to have mol. wt. of and 2.2 x 106 respectively. CsC1 density equilibrium centrifugation of complete virus from the continuous sucrose gradients revealed one major band which was visible under reflected light and had a mean buoyant density of 1.33 g/ml. When the crude virus from the interface of a 40 to 60 % sucrose step gradient was further purified on CsC1, a second, less dense, band was frequently seen which appeared by electron microscopy to contain a high proportion of 'core' particles. Eflect of the duration of infection on the yield of virus No band of IBD virus was visible in CsCI gradients of virus from bursae harvested from chickens 2 days after infection. A distinct band of virus was visible in CsC1 gradients of bursae from chickens infected for 3 days, but was more diffuse when the virus was purified from bursae harvested 4 days after infection. An ELISA for IBD viral antigen also found maximum titres of antigen in bursal homogenates obtained 3 or 4 days after infection. Consequently, virus was routinely prepared from bursae that were collected 3 days after infection. Amino acid analysis of an acid hydrolysate, assuming a mean amino acid residue mol. wt. of 110, showed that up to 250 I-tg of viral protein could be obtained from a single bursa. Coomassie Brilliant Blue staining after SDS-PAGE of purified virus As shown in Fig. 1, purified preparations of intact virus contained two major polypeptides with approximate mol. wt. of 37K and 32K, and three other components (arrows in Fig. 1) of approximate mol. wt. 91.5K, 41.5K and 29K. Although the polypeptide of tool. wt. 32K was a major component of all preparations of virus, densitometer tracings from polyacrylamide gels of different preparations of virus revealed that the relative amounts of the other polypeptides, particularly the 41-5K polypeptide, varied between preparations. Kinetics and specificity of the primary antibody response of chickens infected with IBD virus The appearance of serum antibody to IBD virus, as determined by ELISA, was followed in six SPF chickens infected intraocularly at 6 weeks of age with isolate 002/73. Antibody was first detected on day 5 (mean titre 250), rising quickly to a mean titre of on day 10 and on day 14. The analyses by Western blotting of the sera obtained from one of these chickens is shown in Fig. 2. Antibody binding to the 32K polypeptide of IBD virus was detected on day 5, with the intensity of the bands increasing with time after infection. The antibodies present in the circulation of this chicken remained relatively specific for the 32K polypeptide, at least until day

4 1482 (a) K. J. FAHEY, I. J. O'DONNELL AND A. A. AZAD (b) Fig. 1. (a) PAGE of purified IBD virus in a 12-5~ gel. The gel was stained with Coomassie Brilliant Blue (a) to reveal two major bands of approximate mol. wt. 37K and 32K and three others (arrowed) of approximate mol. wt. 91.5K, 41.5K and 29K. (b) Autoradiograph of a Western blot of virus preparation from (a) after probing with serum from a chicken experimentally infected with live IBD virus 2 months previously. Mol. wt. standards are on the left-hand side of each gel [(a) Pharmacia standards and (b) Amersham ~C standards; mol. wt. 10-3]. 14 of the response. Western blots of the antibody present in sera obtained 14 days after infection from all six chickens are shown in Fig. 3 (lanes 1 to 6). The early antibody response of all chickens was predominantly to the 32K polypeptide and the response of five of the six chickens appeared to be monospecific (Fig. 3, lanes 2 to 6), even when the autoradiographs were exposed for 7 days. By 28 days after a primary infection the chickens had produced antibodies to all IBD virus polypeptides, except the 91.5K polypeptide (Fig. 3, lane 7). Response oj SPF chickens to vaccination with an inactivated oil-emulsion IBD vaccine Six chickens, when 5 weeks of age, were injected intramuscularly with 1 ml of a commercial inactivated whole virus vaccine. The sera from the two chickens with the highest ELISA titres at 8 weeks post-vaccination (titres of and respectively) were analysed by Western blotting. At 4 and 8 weeks after vaccination the primary antibody response of both chickens to the inactivated vaccine was relatively specific for the 32K polypeptide of IBD virus (Fig. 4a, b). By 4 weeks after a second intramuscular injection of inactivated vaccine at 13 weeks of age, however, both chickens had produced serum antibodies which reacted with at least three of the structural proteins (Fig. 4c). Response of sensitized chickens to an inactivated oil-emulsion IBD vaccine Chickens that had been given live IBD virus at 5 weeks of age were injected at 25 weeks of age with a commercial inactivated vaccine. Sera were obtained 4 weeks and 20 weeks after the primary infection and then 4 and 8 weeks following revaccination. Analysis by Western blotting showed that initially there had been a response to four of the structural proteins, which had

5 lmmunogens of IBD virus Time post-infection (days) ~,- 69 ~- 46 D- 30 D ~, Fig. 2. Specificity of the serum antibody response of a 6-week-old chicken to live IBD virus, as assessed by reacting I : 500 dilutions of serum collected 3, 5, 7, 10 and 14 days after infection, with Western blots of the viral polypeptides separated by SDS PAGE. ~C mol. wt. standards are on the left-hand side. waned by 20 weeks post-infection (Fig. 5). An injection of inactivated vaccine at that time resulted in a heightened response to all the IBD viral polypeptides, including the 91.5K polypeptide (Fig. 5d). These hyperimmune sera, in particular, also reacted with several other viral antigens with mol. wt. between 50K and 90K. DISCUSSION Initially, difficulties were encountered in purifying intact virus which seemed to relate to the titre of the virus inoculum, the time after infection that the bursae were harvested, the storage of bursal homogenates at - 80 C for extended periods of time prior to purification and finally the detection of intact virus in the sucrose gradients. SDS-PAGE and ELISA identified viral proteins and antigens respectively, but did not discriminate between intact virus and soluble viral proteins. The analysis of dsrna readily located the intact virus in the gradient; the position was confirmed subsequently by electron microscopy. Studies on the Cu-1 isolate of IBD virus grown in vitro (Dobos, 1979) or in vivo (M/iller & Becht, 1982) detected two major structural proteins with mol. wt. ranging from 40K to 41K (VP- 2) and 32K to 35K (VP-3) respectively, although Todd & McNulty (1979), studying an isolate from Alabama, U.S.A., reported three major polypeptides of mol. wt. 50K, 45K and 30K respectively. When the Australian isolate of IBD virus (002/73) was purified from infected bursae by rate-zonal and density equilibrium centrifugation and analysed by polyacrylamide gel

6 1484 K. J. FAHEY, I. J. O'DONNELL AND A. A. AZAD Chicken number D 69 b ~, Fig. 3. Specificity of antibodies in serum collected from six 6-week-old chickens, 14 days after they had been infected with IBD virus (lanes 1 to 6) or in serum from a chicken that had been infected 28 days previously (lane 7). Only one (lane 1) of the six chickens had antibody with demonstrable specificity for other than the 32K polypeptide by 14 days after infection. Autoradiograph exposed for 7 days. 14 C mol. wt. standards are on the left-hand side. electrophoresis in reducing or non-reducing buffers, two major structural proteins with approximate mol. wt. of 37K and 32K and three other proteins of approximate mol. wt. 91.5K, 41-5K and 29K were present in all preparations of purified virus having a buoyant density of 1.33 g/ml. While the major 32K structural polypeptide of the Australian isolate is comparable in size to VP-3 described for overseas isolates of IBD virus (Dobos, 1979; Todd & McNulty, 1979; Mfiller & Becht, 1982), the major 37K polypeptide of the Australian virus is smaller than the VP- 2 of overseas isolates and the 47K to 48K VP-X described by Dobos (1979) and Mfiller & Becht (1982) was not detected in preparations of intact Australian virus. Preliminary results from HPLC analysis of trypsin digests of the structural polypeptides of the Australian virus indicate that the 37K polypeptide is cleaved from the 41.5K protein (N. M. McKern et al., unpublished data). Although direct comparison with Cu-1 or other exotic isolates of IBD virus is not possible in Australia, the Australian isolate has been serologically confirmed as type 1 IBD virus and the virus has the same size, dsrna genome, tissue specificity and buoyant density as those described for overseas isolates. Variations in techniques, particularly the percentage of polyacrylamide in the gels (10 to 15~), could explain these apparent differences in mol. wt., although the near universality of the major 32K polypeptide suggests that the 37K and its 41-5K precursor polypeptides may be unique to the Australian virus. The relationship, if any, between

7 Immunogens of IBD virus 1485 Chicken number 1 2 I I (a) (b) (c) I (a) (b) (e) Fig. 4. Specificityof the primary antibody response of two SPF chickens (1 and 2) injected at 5 weeks of age with a commercial inactivated oil-emulsion vaccine. Sera obtained from the chickens 4 weeks (a) and 8 weeks (b) after primary vaccination are compared with serum obtained 4 weeks (c) after a second injection of inactivated vaccine at 13 weeks of age. J4C mol. wt. standards are on the left-hand side. the size of VP-2 of the Australian virus and its relatively low pathogenicity in susceptible chickens (compared with overseas reports) awaits resolution. The Australian virus was found to contain two segments of d s R N A which, by comparison with 2 D N A standards, had mol. wt. of 2.2K and 2.5K, similar to those reported for Cu-1 by M/filler et al. (1979). The d s R N A found near the top of the sucrose gradient could represent either partially completed virus, viral R N A associated with cellular organelles or the 'top component' of M/filler & Becht (1982) or the 'empty particles' of Todd & McNulty (1979), both of which are devoid of VP-3. When Western blots of the polypeptides of the Australian isolate of IBD virus were reacted with antibodies from chickens infected at least 4 weeks previously with 002/73 or hyperimmunized with an inactivated oil-emulsion vaccine, all structural proteins of the Australian isolate were found to be immunogenic except the minor 91.5K polypeptide. The latter observation may be a technical artefact due to variability in the efficiency of Western

8 1486 K. J, FAHEY, I. J. O'DONNELL AND A. A. AZAD 92.5 D, (a) (b) (c) (d) 69 D, 46 ~, 30 ~" 14-3~ Fig. 5. Specificity of antibodies in sera from a chicken infected at 5 weeks of age with live virus was examined 4 and 20 weeks post-infection (a, b). The chicken was then re-immunized with a commercial inactivated whole virus vaccine at 25 weeks of age and the specificity of the response examined 4 and 8 weeks later (c, d). ~C mol. wt. standards are on the left-hand side. blotting of high mol, wt. proteins, as antibodies to the 91.5K polypeptide were detected occasionally with hyperimmune serum (Fig. 5). The antibody response to a single injection of inactivated vaccine was directed primarily against the 32K viral polypeptide, as was the early antibody response to the live virus vaccine. After the first 2 weeks post-infection, however, the response to live virus became progessively broader, possibly as a result of the greater antigenic challenge following virus replication in the infected chickens, compared with the limited amount of antigen in a single dose of inactivated vaccine, The relatively specific response of chickens injected with the inactivated vaccine to the 32K polypeptide highlighted the immunogenicity of this polypeptide, compared for example with the 37K polypeptide which was present in comparable amounts in most preparations of virus. The broader specificity of the response to a second injection of inactivated vaccine indicated that the chickens had been successfully primed by the first injection of inactivated vaccine. A single injection of inactivated vaccine also recalled a poly-specific antibody response in chickens previously sensitized with live virus. These hyperimmune sera also recognized a number of other viral antigens with mol. wt. between 50K and 90K, possibly representing precursor forms of the viral proteins, including the 52K translation product detected in vitro by Azad eta/. (1985). Interestingly, while all these positive sera contained antibodies that reacted

9 lmmunogens of IBD virus 1487 with the 32K polypeptide, no serum was found that reacted with the 37K but not the 41.5K polypeptide, or vice versa. Antibodies to these structural proteins arose simultaneously, which further supports the view that the 41.5K polypeptide is the precursor of the 37K polypeptide. An alternative explanation for the reported specificity of the early antibody response for the 32K polypeptide could be that epitopes on the other polypeptides, possibly even ones important in protection, have been destroyed by denaturation during the Western blotting procedure (Cohen et al., 1984). If this were so then these labile epitopes must be the only ones recognized on these polypeptides early in the response, as convalescent serum and hyperimmune serum contain antibodies to stable epitopes on the 37K and 41.5K polypeptides. Since we have not as yet found a way of disrupting the virus using non-denaturing conditions, this possibility has not been investigated. Other possibilities are that early antibodies to the other polypeptides are of too low affinity to be detected by Western blotting or that these antibodies are of the IgM class. That all such antibodies would be too weak to bind to the denatured proteins seems unlikely, since we have now examined the polyclonal response of over 20 chickens and prolonged exposure of the autoradiographs (3 to 7 days, Fig. 3) revealed no non-32k antibody in the majority of early (less than day 14) sera. We know from fractionating immune chicken serum by column chromatography that the chickens are producing both IgM and IgG antibodies early in the response and that the rabbit anti-chicken IgG (H + L) reagent used routinely in our Western blotting analysis primarily detects IgG antibodies (unpublished data). Practically, this is not of particular concern, as it is only the IgG antibodies that are transferred via the yolk to the progeny chickens (Higgins, 1975) and hence responsible for passive immunity. However, reacting Western blots of whole virus with sheep anti-chicken IgM serum did not reveal the presence of antibodies to the other structural polypeptides of IBD virus in putative anti-32k specific sera (unpublished data). Accepting the possibility that important immunogenic sites on the other structural polypeptides of IBD virus may be destroyed by denaturation, our evidence suggests that the first antibodies produced by the majority of chickens infected with IBD virus or injected with an inactivated vaccine, are specific for the 32K viral polypeptide and only later in the response or following re-vaccination with an inactivated vaccine could antibodies to the other structural proteins be readily detected. The recognition of the 32K polypeptide as a major immunogen of IBD virus has given impetus and direction to the development of a subunit vaccine for IBD by recombinant DNA technology. The authors gratefully acknowledge the advice and helpful discussion of Drs C. W. Ward, K. Gough and T. J. Bagust and the excellent technical assistance of Ms S. Arendshorst and Ms J. Crooks. Mr J. E. Peterson kindly performed the electron microscopic examination of the purified virus. These studies were assisted financially by the Australian Chicken Meat Research Committee and the Poultry Research Advisory Committee of the Council of Egg Marketing Authorities of Australia. REFERENCES AZAD, A. A., BARRETT, S. A. & FAHEY, K. J. (1985). The characterization and molecular cloning of the double-stranded RNA genome of an Australian strain of infectious bursal disease virus. Virology (in press). BURNETTE, W. N. (1981). 'Western blotting': electrophoretic transfer of proteins from sodium dodecyl sulfatepolyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Analytical Biochemistry 112, COHEN, B. B., MOXLEY, M., CRICHTON, D., DEANE, D. L. & STEEL, C. M. (1984). A mild procedure for separating polypeptide chains prior to immunoprecipitation and Western blotting analysis. Journal oflmmunological Methods 75, oobos, p. (1979). Peptide map comparison of the proteins of infectious bursal disease virus. Journal of Virology 32, FIRTH, G. A. (1974). Occurrence of an infectious bursal syndrome within an Australian poultry flock. Australian Veterinary Journal 50, HIGGINS, D. A. (1975). Physical and chemical properties of fowlimmunoglobulins. Veterinary Bu/letin 45, LAEMMLI, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage "I"4. Nature, London 227, McMASTER, G. K. & CARMICHAEL, G. C. (1977). Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange. Proceedings of the National Academy of Sciences, U.S.A. 74,

10 1488 K. J. FAHEY, I. J. O'DONNELL AND A. A. AZAD MULLER, H. & BECIqT, H. (1982). Biosynthesis of virus-specific proteins in cells infected with infectious bursal disease virus and their significance as structural elements for infectious virus and incomplete particles. Journal of Virology 44, MULLER, H., SCHOLTISSEK, C- & BECHT, H. (1979). The genome of infectious bursal disease virus consists of two segments of double-stranded RNA. Journal of Virology 31, NICK, H., CURSIEFEN, G. & aecht, 8. (1976). Structural and growth characteristics of infectious bursal disease virus. Journal o[ Virology 18, TODD, D. & McNULTY, M. S. ([ 979). Biochemical studies with infectious bursal disease virus: comparison of some of its properties with infectious pancreatic necrosis virus. Archives of Virology 60, WYETH, P. J. & CHETrLE, N. (1982). Comparison of the efficacy of four inactivated infectious bursal disease oil emulsion vaccines. Veterinary Record ll0, WYETH, P. J., O'8RIEN, J. D. P. & CULLEN, G. A. (1981). Improved performance of progeny of broiler parent chickens vaccinated with infectious bursal disease oil-emulsion vaccine. Avian Diseases 25, YORK, J. J., FAHEY, K. J. & BAGUST, T. J. (1983). Development and evaluation of an ELISA for the detection of antibody to infectious laryngotracheitis virus in chickens. Avian Diseases 27, (Received 6 November 1984)

G. W. WOOD J. C. MUSKETT and D. H. THORNTON MAFF, Central Veterinary Laboratory, New Haw, Weybridge, Surrey, U.K.

G. W. WOOD J. C. MUSKETT and D. H. THORNTON MAFF, Central Veterinary Laboratory, New Haw, Weybridge, Surrey, U.K. J. Comp. Path. 1986 vol. 96 OBSERVATIONS ON THE ABILITY OF AVIAN REOVIRUS VACCINMATION OF HENS TO PROTECT THEIR PROGENY AGAINST THE EFFECTS OF CHALLENGE WITH HOMOLOGOUS AND HETEROLOGOUS STRAINS By G. W.

More information

BY F. BROWN, B. CARTWRIGHT AND DOREEN L. STEWART Research Institute (Animal Virus Diseases), Pirbright, Surrey. (Received 22 August 1962) SUMMARY

BY F. BROWN, B. CARTWRIGHT AND DOREEN L. STEWART Research Institute (Animal Virus Diseases), Pirbright, Surrey. (Received 22 August 1962) SUMMARY J. gen. Microbial. (1963), 31, 179186 Prinied in Great Britain 179 The Effect of Various Inactivating Agents on the Viral and Ribonucleic Acid Infectivities of FootandMouth Disease Virus and on its Attachment

More information

Genomic Alterations Associated with Persistent Infections by Equine Infectious Anaemia Virus, a Retrovirus

Genomic Alterations Associated with Persistent Infections by Equine Infectious Anaemia Virus, a Retrovirus J. gen. Virol. (1984), 65, 1395-1399. Printed in Great Britain 1395 Key words: EIA V/retrovirus persistence~antigenic variation/oligonucleotide mapping Genomic Alterations Associated with Persistent Infections

More information

Neutralization Epitopes on Poliovirus Type 3 Particles: an Analysis Using Monoclonal Antibodies

Neutralization Epitopes on Poliovirus Type 3 Particles: an Analysis Using Monoclonal Antibodies J.-gen. Virol. (1984), 65, 197-201. Printed in Great Britain 197 Key words: poliovirus type 3/monoclonal Abs/neutralization/immunoblot Neutralization Epitopes on Poliovirus Type 3 Particles: an Analysis

More information

CHARACTERISATION OF INFECTIOUS BURSAL DISEASE VIRUS AND DETERMINATION OF POSSIBLE VACCINE STRAIN(S) IN KENYA

CHARACTERISATION OF INFECTIOUS BURSAL DISEASE VIRUS AND DETERMINATION OF POSSIBLE VACCINE STRAIN(S) IN KENYA CHARACTERISATION OF INFECTIOUS BURSAL DISEASE VIRUS AND DETERMINATION OF POSSIBLE VACCINE STRAIN(S) IN KENYA Investigator: Dr. Mutinda, W.U (BVM, MSc.) Supervisors: Prof. P.N Nyaga, BVM, MSc, PhD Prof.

More information

The Protective Antigen of a Highly Immunogenic Strain of Clostridium chauvoei Including an Evaluation of Its Flagella as a Protective Antigen

The Protective Antigen of a Highly Immunogenic Strain of Clostridium chauvoei Including an Evaluation of Its Flagella as a Protective Antigen 128 Journal of General Microbiology (1974), 84, 128-134 Printed in Great Britain The Protective Antigen of a Highly Immunogenic Strain of Clostridium chauvoei Including an Evaluation of Its Flagella as

More information

SUPPLEMENTARY MATERIAL

SUPPLEMENTARY MATERIAL SUPPLEMENTARY MATERIAL Purification and biochemical properties of SDS-stable low molecular weight alkaline serine protease from Citrullus Colocynthis Muhammad Bashir Khan, 1,3 Hidayatullah khan, 2 Muhammad

More information

Astrovirus-associated gastroenteritis in children

Astrovirus-associated gastroenteritis in children Journal of Clinical Pathology, 1978, 31, 939-943 Astrovirus-associated gastroenteritis in children C. R. ASHLEY, E. 0. CAUL, AND W. K. PAVER1 From the Public Health Laboratory, Myrtle Road, Bristol BS2

More information

Amino Acid Composition of Polypeptides from Influenza Virus Particles

Amino Acid Composition of Polypeptides from Influenza Virus Particles J. gen. Virol. 0972), x7, 61-67 Printed in Great Britain 6x Amino Acid Composition of Polypeptides from Influenza Virus Particles By W. G. LAVER AND NICOLA BAKER Department of Microbiology, The John Curtin

More information

Detection of vvibdv strains and Australian variants in poultry

Detection of vvibdv strains and Australian variants in poultry Detection of vvibdv strains and Australian variants in poultry A report for the Rural Industries Research and Development Corporation by J. Ignjatovic, S. Sapats and G. Gould November 2001 RIRDC Publication

More information

Recommended laboratory tests to identify influenza A/H5 virus in specimens from patients with an influenza-like illness

Recommended laboratory tests to identify influenza A/H5 virus in specimens from patients with an influenza-like illness World Health Organization Recommended laboratory tests to identify influenza A/H5 virus in specimens from patients with an influenza-like illness General information Highly pathogenic avian influenza (HPAI)

More information

virus-i (RAV-1) or Rous associated virus-2 (RAV-2), do not transform but do produce

virus-i (RAV-1) or Rous associated virus-2 (RAV-2), do not transform but do produce ISOLATION OF NONINFECTIOUS PARTICLES CONTAINING ROUS SARCOMA VIRUS RNA FROM THE MEDIUM OF ROUS SARCOMA VIRUS-TRANSFORMED NONPRODUCER CELLS* BY HARRIET LATHAM ROBINSONt VIRUS LABORATORY, UNIVERSITY OF CALIFORNIA,

More information

Avian Infectious Bronchitis Vaccine, Inactivated

Avian Infectious Bronchitis Vaccine, Inactivated Avian Infectious Bronchitis Vaccine, Inactivated Avian Infectious Bronchitis Vaccine, Inactivated consists of an emulsion or a suspension of one or more serotypes of avian infectious bronchitis virus which

More information

Annex 5. Generic protocol for the calibration of seasonal and pandemic influenza antigen working reagents by WHO essential regulatory laboratories

Annex 5. Generic protocol for the calibration of seasonal and pandemic influenza antigen working reagents by WHO essential regulatory laboratories Annex 5 Generic protocol for the calibration of seasonal and pandemic influenza antigen working reagents by WHO essential regulatory laboratories Abbreviations 262 1. Introduction 262 2. Essential regulatory

More information

Protocol for Gene Transfection & Western Blotting

Protocol for Gene Transfection & Western Blotting The schedule and the manual of basic techniques for cell culture Advanced Protocol for Gene Transfection & Western Blotting Schedule Day 1 26/07/2008 Transfection Day 3 28/07/2008 Cell lysis Immunoprecipitation

More information

Antigenic Analysis of Isolated Polypeptides from Visna Virus

Antigenic Analysis of Isolated Polypeptides from Visna Virus INFECTION AND IMMUNITY, June 1976, p. 1728-1732 Copyright 1976 American Society for Microbiology Vol. 13, No. 6 Printed in USA. Antigenic Analysis of Isolated Polypeptides from Visna Virus P. D. MEHTA,*

More information

Mammalian Membrane Protein Extraction Kit

Mammalian Membrane Protein Extraction Kit Mammalian Membrane Protein Extraction Kit Catalog number: AR0155 Boster s Mammalian Membrane Protein Extraction Kit is a simple, rapid and reproducible method to prepare cellular protein fractions highly

More information

Work-flow: protein sample preparation Precipitation methods Removal of interfering substances Specific examples:

Work-flow: protein sample preparation Precipitation methods Removal of interfering substances Specific examples: Dr. Sanjeeva Srivastava IIT Bombay Work-flow: protein sample preparation Precipitation methods Removal of interfering substances Specific examples: Sample preparation for serum proteome analysis Sample

More information

THE CYTOPATHOGENIC ACTION OF BLUETONGUE VIRUS ON TISSUE CULTURES AND ITS APPLICATION TO THE DETECTION OF ANTIBODIES IN THE SERUM OF SHEEP.

THE CYTOPATHOGENIC ACTION OF BLUETONGUE VIRUS ON TISSUE CULTURES AND ITS APPLICATION TO THE DETECTION OF ANTIBODIES IN THE SERUM OF SHEEP. Onderstepoort Journal of Veterinary Research, Volume 27, Number 2, October, 1956. The Government Printer. THE CYTOPATHOGENIC ACTION OF BLUETONGUE VIRUS ON TISSUE CULTURES AND ITS APPLICATION TO THE DETECTION

More information

Influenza or flu is a

Influenza or flu is a Clinical and Research Area Infectious Diseases Influenza Virus Types A and B Influenza or flu is a respiratory illness that is caused by influenza viruses. Influenza viruses type A and type B cause seasonal

More information

INCLUSION BODY HEPATITIS AND HYDROPERICARDIUM SYNDROME (ADENOVIRUS INFECTIONS)

INCLUSION BODY HEPATITIS AND HYDROPERICARDIUM SYNDROME (ADENOVIRUS INFECTIONS) INCLUSION BODY HEPATITIS AND HYDROPERICARDIUM SYNDROME (ADENOVIRUS INFECTIONS) AVIAN ADENOVIRUSES (CHICKEN ADENOVIRUSES, FADV) Adenoviruses are common in poultry. Many replicate in healthy birds without

More information

Summary of Product Characteristics

Summary of Product Characteristics Health Products Regulatory Authority Summary of Product Characteristics 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Novamune concentrate and solvent for suspension for injection for chickens 2 QUALITATIVE

More information

Protocol for protein SDS PAGE and Transfer

Protocol for protein SDS PAGE and Transfer Protocol for protein SDS PAGE and Transfer According to Laemmli, (1970) Alaa El -Din Hamid Sayed, Alaa_h254@yahoo.com Serum Selection of a protein source cell cultures (bacteria, yeast, mammalian, etc.)

More information

Human HBcAb IgM ELISA kit

Human HBcAb IgM ELISA kit Human HBcAb IgM ELISA kit Catalog number: NR-R10163 (96 wells) The kit is designed to qualitatively detect HBcAb IgM in human serum or plasma. FOR RESEARCH USE ONLY. NOT FOR DIAGNOSTIC OR THERAPEUTIC PURPOSES

More information

Specificity of IgM Antibodies in Acute Human Coxsackievirus B Infections, Analysed by Indirect Solid Phase Enzyme Immunoassay and lmmunoblot Technique

Specificity of IgM Antibodies in Acute Human Coxsackievirus B Infections, Analysed by Indirect Solid Phase Enzyme Immunoassay and lmmunoblot Technique J. gen. Virol. (1983), 64, 159-167. Printed in Great Britain 159 Key words: coxsackievirus B/immunoglobulin M response/elisa/protein-blot Specificity of IgM Antibodies in Acute Human Coxsackievirus B Infections,

More information

E.Z.N.A. SQ Blood DNA Kit II. Table of Contents

E.Z.N.A. SQ Blood DNA Kit II. Table of Contents E.Z.N.A. SQ Blood DNA Kit II Table of Contents Introduction and Overview...2 Kit Contents/Storage and Stability...3 Blood Storage and DNA Yield...4 Preparing Reagents...5 100-500 μl Whole Blood Protocol...6

More information

ab Glycated Protein Detection Kit

ab Glycated Protein Detection Kit Version 1 Last updated 27 July 2017 ab219802 Glycated Protein Detection Kit For the detection of glycated proteins (AGEs) using a simple polyacrylamide gel electrophoresis-based method. This product is

More information

however, and the present communication is concerned with some of

however, and the present communication is concerned with some of THE AGGLUTINATION OF HUMAN ERYTHROCYTES MODIFIED BY TREATMENT WITH NEWCASTLE DISEASE AND INFLUENZA VIRUS' ALFRED L. FLORMAN' Pediatric Service and Division of Bacteriology, The Mount Sinai Hospital, New

More information

Reagents for the Typing of Human Influenza Isolates 2011

Reagents for the Typing of Human Influenza Isolates 2011 Reagents for the Typing of Human Influenza Isolates 2011 This product was developed by the Victorian Infectious Diseases Reference Laboratory (VIDRL) in its capacity as a WHO Collaborating Centre for Reference

More information

Biotechnology-Based Vaccines. Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel:

Biotechnology-Based Vaccines. Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: Biotechnology-Based Vaccines Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa Objectives of this lecture By the end of this lecture you will be able to: 1.

More information

Variation in the HindlII Restriction Fragments of DNA from the Chinese Tian Tan Strain of Vaccinia Virus

Variation in the HindlII Restriction Fragments of DNA from the Chinese Tian Tan Strain of Vaccinia Virus J. gen. irol. (1985), 66, 1819-1823. Printed in Great Britain 1819 Key words: vaccinia virus~vaccine~restriction Jragrnent variation ariation in the Hindl Restriction Fragments of DNA from the Chinese

More information

To detect antibodies to Avian Influenza (AI) using the haemagglutination inhibition test in avian serum specimens 2.

To detect antibodies to Avian Influenza (AI) using the haemagglutination inhibition test in avian serum specimens 2. SADC Harmonized SOP for Avian Influenza HA and HI Serological Tests Prepared by: Dr. P.V. Makaya, Dr. Joule Kangumba and Ms Delille Wessels Reviewed by Dr. P.V. Makaya 1. Purpose and scope To detect antibodies

More information

A report for the Rural Industries Research and Development Corporation. by Dr. David B. Boyle. September 2003

A report for the Rural Industries Research and Development Corporation. by Dr. David B. Boyle. September 2003 NEW FOWL POX VACCINE EVALUATION Evaluation of fowl pox (FPV) strains free of reticuloendotheliosis virus as vaccines for use in Australian poultry flocks A report for the Rural Industries Research and

More information

Annexure III SOLUTIONS AND REAGENTS

Annexure III SOLUTIONS AND REAGENTS Annexure III SOLUTIONS AND REAGENTS A. STOCK SOLUTIONS FOR DNA ISOLATION 0.5M Ethylene-diamine tetra acetic acid (EDTA) (ph=8.0) 1M Tris-Cl (ph=8.0) 5M NaCl solution Red cell lysis buffer (10X) White cell

More information

The Schedule and the Manual of Basic Techniques for Cell Culture

The Schedule and the Manual of Basic Techniques for Cell Culture The Schedule and the Manual of Basic Techniques for Cell Culture 1 Materials Calcium Phosphate Transfection Kit: Invitrogen Cat.No.K2780-01 Falcon tube (Cat No.35-2054:12 x 75 mm, 5 ml tube) Cell: 293

More information

Identification of Microbes Lecture: 12

Identification of Microbes Lecture: 12 Diagnostic Microbiology Identification of Microbes Lecture: 12 Electron Microscopy 106 virus particles per ml required for visualization, 50,000-60,000 magnification normally used. Viruses may be detected

More information

HiPer Western Blotting Teaching Kit

HiPer Western Blotting Teaching Kit HiPer Western Blotting Teaching Kit Product Code: HTI009 Number of experiments that can be performed: 5/20 Duration of Experiment: ~ 2 days Day 1: 6-8 hours (SDS- PAGE and Electroblotting) Day 2: 3 hours

More information

Influenza A H7N9 (A/Anhui/1/2013) Hemagglutinin / HA ELISA Pair Set

Influenza A H7N9 (A/Anhui/1/2013) Hemagglutinin / HA ELISA Pair Set Influenza A H7N9 (A/Anhui/1/2013) Hemagglutinin / HA ELISA Pair Set Catalog Number : SEK40103 To achieve the best assay results, this manual must be read carefully before using this product and the assay

More information

CHAPTER 4 IMMUNOLOGICAL TECHNIQUES

CHAPTER 4 IMMUNOLOGICAL TECHNIQUES CHAPTER 4 IMMUNOLOGICAL TECHNIQUES Nitroblue Tetrazolium Chloride (NBT) Reduction test NBT reduction test was evaluated by employing the method described by Hudson and Hay,1989 based upon principle that

More information

Influenza B Hemagglutinin / HA ELISA Pair Set

Influenza B Hemagglutinin / HA ELISA Pair Set Influenza B Hemagglutinin / HA ELISA Pair Set Catalog Number : SEK11053 To achieve the best assay results, this manual must be read carefully before using this product and the assay is run as summarized

More information

This product was developed by the Victorian Infectious Diseases Reference Laboratory (VIDRL) in its capacity as a WHO Collaborating Centre for

This product was developed by the Victorian Infectious Diseases Reference Laboratory (VIDRL) in its capacity as a WHO Collaborating Centre for This product was developed by the Victorian Infectious Diseases Reference Laboratory (VIDRL) in its capacity as a WHO Collaborating Centre for Reference and Research on Influenza, with material provided

More information

Formation of an Infectious Virus-Antibody Complex with Rous

Formation of an Infectious Virus-Antibody Complex with Rous JOURNAL OF VIROLOGY, Mar. 1976, p. 163-167 Copyright 1976 American Society for Microbiology Vol. 17, No. 3 Printed in U.S.A. Formation of an Infectious Virus-Antibody Complex with Rous Sarcoma Virus and

More information

Recombinant Virus Vaccine for Bluetongue Disease in Sheep

Recombinant Virus Vaccine for Bluetongue Disease in Sheep JOURNAL OF VIROLOGY, May 1990, p. 1998-2003 Vol. 64, No. 5 0022-538X/90/051998-06$02.00/0 Copyright 1990, American Society for Microbiology Recombinant Virus Vaccine for Bluetongue Disease in Sheep P.

More information

SYNOPSIS STUDIES ON THE PREPARATION AND CHARACTERISATION OF PROTEIN HYDROLYSATES FROM GROUNDNUT AND SOYBEAN ISOLATES

SYNOPSIS STUDIES ON THE PREPARATION AND CHARACTERISATION OF PROTEIN HYDROLYSATES FROM GROUNDNUT AND SOYBEAN ISOLATES 1 SYNOPSIS STUDIES ON THE PREPARATION AND CHARACTERISATION OF PROTEIN HYDROLYSATES FROM GROUNDNUT AND SOYBEAN ISOLATES Proteins are important in food processing and food product development, as they are

More information

Laboratory Diagnosis of Avian Influenza and Newcastle Disease

Laboratory Diagnosis of Avian Influenza and Newcastle Disease Laboratory Diagnosis of Avian Influenza and Newcastle Disease Dennis A. Senne dennis.a.senne@aphis.usda.gov (515) 239-7551 U. S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary

More information

Dental Research Institute, Faculty of Dentistry, University of Toronto, Toronto, Canada *For correspondence:

Dental Research Institute, Faculty of Dentistry, University of Toronto, Toronto, Canada *For correspondence: Zymogram Assay for the Detection of Peptidoglycan Hydrolases in Streptococcus mutans Delphine Dufour and Céline M. Lévesque * Dental Research Institute, Faculty of Dentistry, University of Toronto, Toronto,

More information

Ethylenediaminetetraacetate

Ethylenediaminetetraacetate APPLIED AND ENVIRONMENTAL MICROBIOLOGY, June 1980, p. 1148-1153 0099-2240/80/06-1148/06$02.00/0 Vol. 39, No. 6 Comparative Study on the Mechanisms of Rotavirus Inactivation by Sodium Dodecyl Sulfate and

More information

REVIEW ARTICLE. Biochemistry and Immunology of Infectious Bursal Disease Virus

REVIEW ARTICLE. Biochemistry and Immunology of Infectious Bursal Disease Virus J. gen. Virol. (1988), 69, 1757-1775. Printed in Great Britain 1757 Key words: IBD V/molecular structure/immunology/birnaviruses REVIEW ARTICLE Biochemistry and Immunology of Infectious Bursal Disease

More information

Human Immunodeficiency Virus type 1 (HIV-1) p24 / Capsid Protein p24 ELISA Pair Set

Human Immunodeficiency Virus type 1 (HIV-1) p24 / Capsid Protein p24 ELISA Pair Set Human Immunodeficiency Virus type 1 (HIV-1) p24 / Capsid Protein p24 ELISA Pair Set Catalog Number : SEK11695 To achieve the best assay results, this manual must be read carefully before using this product

More information

HIV-1 p24 ELISA Pair Set Cat#: orb54951 (ELISA Manual)

HIV-1 p24 ELISA Pair Set Cat#: orb54951 (ELISA Manual) HIV-1 p24 ELISA Pair Set Cat#: orb54951 (ELISA Manual) BACKGROUND Human Immunodeficiency Virus ( HIV ) can be divided into two major types, HIV type 1 (HIV-1) and HIV type 2 (HIV-2). HIV-1 is related to

More information

SURVEILLANCE TECHNICAL

SURVEILLANCE TECHNICAL CHAPTER 5 SURVEILLANCE TECHNICAL ASPECTS 55 Protect - detect - protect Polio eradication strategies can be summed up as protect and detect protect children against polio by vaccinating them, and detect

More information

SCIENTIFIC DISCUSSION

SCIENTIFIC DISCUSSION SCIENTIFIC DISCUSSION 1. SUMMARY OF THE DOSSIER Nobilis Influenza H5N2 emulsion for injection, is an adjuvanted, inactivated vaccine against avian influenza type A, subtype H5 in chickens. Avian influenza

More information

Ralf Wagner Paul-Ehrlich-Institut

Ralf Wagner Paul-Ehrlich-Institut www.pei.de Other Assays for the Detection of Neuraminidase (NA)-Specific Antibodies Ralf Wagner Paul-Ehrlich-Institut Overview to presented assays Assay principle based on: Chemical substrates: Protein

More information

The Infectious Cycle. Lecture 2 Biology W3310/4310 Virology Spring You know my methods, Watson --SIR ARTHUR CONAN DOYLE

The Infectious Cycle. Lecture 2 Biology W3310/4310 Virology Spring You know my methods, Watson --SIR ARTHUR CONAN DOYLE The Infectious Cycle Lecture 2 Biology W3310/4310 Virology Spring 2016 You know my methods, Watson --SIR ARTHUR CONAN DOYLE The Infectious Cycle Virologists divide the infectious cycle into steps to facilitate

More information

The Immunoassay Guide to Successful Mass Spectrometry. Orr Sharpe Robinson Lab SUMS User Meeting October 29, 2013

The Immunoassay Guide to Successful Mass Spectrometry. Orr Sharpe Robinson Lab SUMS User Meeting October 29, 2013 The Immunoassay Guide to Successful Mass Spectrometry Orr Sharpe Robinson Lab SUMS User Meeting October 29, 2013 What is it? Hey! Look at that! Something is reacting in here! I just wish I knew what it

More information

CHAPTER 4 RESULTS. showed that all three replicates had similar growth trends (Figure 4.1) (p<0.05; p=0.0000)

CHAPTER 4 RESULTS. showed that all three replicates had similar growth trends (Figure 4.1) (p<0.05; p=0.0000) CHAPTER 4 RESULTS 4.1 Growth Characterization of C. vulgaris 4.1.1 Optical Density Growth study of Chlorella vulgaris based on optical density at 620 nm (OD 620 ) showed that all three replicates had similar

More information

VACCINES FOR VETERINARY USE Vaccina ad usum veterinarium

VACCINES FOR VETERINARY USE Vaccina ad usum veterinarium EUROPEAN PHARMACOPOEIA 6.0 Vaccines for veterinary use out,theexpirydateforthefinallotiscalculatedfromthe date of an approved stability-indicating test or failing this fromthedateoffreeze-dryingorthedateoffillingintothe

More information

Ultrastructure of Mycoplasmatales Virus laidlawii x

Ultrastructure of Mycoplasmatales Virus laidlawii x J. gen. Virol. (1972), I6, 215-22I Printed in Great Britain 2I 5 Ultrastructure of Mycoplasmatales Virus laidlawii x By JUDY BRUCE, R. N. GOURLAY, AND D. J. GARWES R. HULL* Agricultural Research Council,

More information

XCF TM COMPLETE Exosome and cfdna Isolation Kit (for Serum & Plasma)

XCF TM COMPLETE Exosome and cfdna Isolation Kit (for Serum & Plasma) XCF TM COMPLETE Exosome and cfdna Isolation Kit (for Serum & Plasma) Cat# XCF100A-1 User Manual Store kit components at +4ºC and +25ºC Version 1 2/2/2017 A limited-use label license covers this product.

More information

Research note. Merial S.A.S., 29 avenue Tony Garnier Lyon cedex 07 France 2

Research note. Merial S.A.S., 29 avenue Tony Garnier Lyon cedex 07 France 2 Research note Monitoring of vaccine take by quantitative realtime polymerase chain reaction following different Marek s disease vaccination programs in future broiler breeders Delvecchio A. 1, Gimeno I.

More information

hemagglutinin and the neuraminidase genes (RNA/recombinant viruses/polyacrylamide gel electrophoresis/genetics)

hemagglutinin and the neuraminidase genes (RNA/recombinant viruses/polyacrylamide gel electrophoresis/genetics) Proc. Natl. Acad. Sci. USA Vol. 73, No. 6, pp. 242-246, June 976 Microbiology Mapping of the influenza virus genome: Identification of the hemagglutinin and the neuraminidase genes (RNA/recombinant viruses/polyacrylamide

More information

Luminescent platforms for monitoring changes in the solubility of amylin and huntingtin in living cells

Luminescent platforms for monitoring changes in the solubility of amylin and huntingtin in living cells Electronic Supplementary Material (ESI) for Molecular BioSystems. This journal is The Royal Society of Chemistry 2016 Contents Supporting Information Luminescent platforms for monitoring changes in the

More information

SCS MOLECULAR WEIGHT MARKERS 2,500-17,000 Caltons

SCS MOLECULAR WEIGHT MARKERS 2,500-17,000 Caltons LECTROPHORES/S Revised November 1992 SCS MOLECULAR WEIGHT MARKERS 2,500-17,000 Caltons I NTRODUCTION Electrophoresis in polyacrylamide gels in the presence of sodium dodecyl sulfate (SDS), an anionic detergent,

More information

Effect of Mutation in Immunodominant Neutralization Epitopes on the Antigenicity of Rotavirus SA-11

Effect of Mutation in Immunodominant Neutralization Epitopes on the Antigenicity of Rotavirus SA-11 J. gen. Virol. (1985), 66, 2375-2381. Printed in Great Britain 2375 Key words: rotaviruses/antigenieity/antiserum selection Effect of Mutation in Immunodominant Neutralization Epitopes on the Antigenicity

More information

PRODUCT INFORMATION & MANUAL

PRODUCT INFORMATION & MANUAL PRODUCT INFORMATION & MANUAL 0.4 micron for Overall Exosome Isolation (Cell Media) NBP2-49826 For research use only. Not for diagnostic or therapeutic procedures. www.novusbio.com - P: 303.730.1950 - P:

More information

130327SCH4U_biochem April 09, 2013

130327SCH4U_biochem April 09, 2013 Option B: B1.1 ENERGY Human Biochemistry If more energy is taken in from food than is used up, weight gain will follow. Similarly if more energy is used than we supply our body with, weight loss will occur.

More information

Norgen s HIV Proviral DNA PCR Kit was developed and validated to be used with the following PCR instruments: Qiagen Rotor-Gene Q BioRad T1000 Cycler

Norgen s HIV Proviral DNA PCR Kit was developed and validated to be used with the following PCR instruments: Qiagen Rotor-Gene Q BioRad T1000 Cycler 3430 Schmon Parkway Thorold, ON, Canada L2V 4Y6 Phone: 866-667-4362 (905) 227-8848 Fax: (905) 227-1061 Email: techsupport@norgenbiotek.com HIV Proviral DNA PCR Kit Product# 33840 Product Insert Intended

More information

Involvement of serine proteinase in infectious pancreatic necrosis virus capsid protein maturation and NS proteinase cleavage in CHSE-214 cells

Involvement of serine proteinase in infectious pancreatic necrosis virus capsid protein maturation and NS proteinase cleavage in CHSE-214 cells Journal of Fish Diseases (1998) 21, 215 220 Involvement of serine proteinase in infectious pancreatic necrosis virus capsid protein maturation and NS proteinase cleavage in CHSE-214 cells J-L Wu 1, J-R

More information

Estimations of the Molecular Weight of the Influenza Virus Genome

Estimations of the Molecular Weight of the Influenza Virus Genome o r. gem Viral. &97I), H, Io3-Io9 103 Printed in Great Britain Estimations of the Molecular Weight of the Influenza Virus Genome By J. J. SKEHEL National Institute for Medical Research, Mill Hill, London

More information

Western Blot Analysis of Rat Pituitar Recognized by Human Antipituitary. y Antigens A. antibodies

Western Blot Analysis of Rat Pituitar Recognized by Human Antipituitary. y Antigens A. antibodies Endocrine Journal 1995, 42(1), 115-119 NOTE Western Blot Analysis of Rat Pituitar Recognized by Human Antipituitary y Antigens A ntibodies SHIGEKI YABE, MASAMI MURAKAMI*, KAYOKO MARUYAMA, HIDEKO MIWA,

More information

Protein MultiColor Stable, Low Range

Protein MultiColor Stable, Low Range Product Name: DynaMarker Protein MultiColor Stable, Low Range Code No: DM670L Lot No: ******* Size: 200 μl x 3 (DM670 x 3) (120 mini-gel lanes) Storage: 4 C Stability: 12 months at 4 C Storage Buffer:

More information

The duration of protective immunity following immunisation is unknown, but is believed to be in excess of five years.

The duration of protective immunity following immunisation is unknown, but is believed to be in excess of five years. Q-VAX Q Fever Vaccine and Q-VAX Skin Test (AUST R 100517 & 100518) Page 1 of 6 NAME OF THE MEDICINE Q fever Vaccine AUST R 100517 Q fever Skin Test AUST R 100518 DESCRIPTION Q-VAX is a purified suspension

More information

Original Article Polyclonal Antibody against Recombinant Nucleoprotein of the Influenza A Virus (H1N1); Production and Purification

Original Article Polyclonal Antibody against Recombinant Nucleoprotein of the Influenza A Virus (H1N1); Production and Purification Iranian J Virol 2017;11(2): 36-42 2017, Iranian Society of Virology. All rights reserved. Original Article Polyclonal Antibody against Recombinant Nucleoprotein of the Influenza A Virus (H1N1); Production

More information

NEUTRALIZATION OF REOVIRUS: THE GENE RESPONSIBLE FOR THE NEUTRALIZATION ANTIGEN* BY HOWARD L. WEINER~ AN~ BERNARD N. FIELDS

NEUTRALIZATION OF REOVIRUS: THE GENE RESPONSIBLE FOR THE NEUTRALIZATION ANTIGEN* BY HOWARD L. WEINER~ AN~ BERNARD N. FIELDS NEUTRALIZATION OF REOVIRUS: THE GENE RESPONSIBLE FOR THE NEUTRALIZATION ANTIGEN* BY HOWARD L. WEINER~ AN~ BERNARD N. FIELDS (From the Department of Microbiology and Molecular Genetics, Harvard Medical

More information

TSH Receptor Monoclonal Antibody (49) Catalog Number MA3-218 Product data sheet

TSH Receptor Monoclonal Antibody (49) Catalog Number MA3-218 Product data sheet Website: thermofisher.com Customer Service (US): 1 800 955 6288 ext. 1 Technical Support (US): 1 800 955 6288 ext. 441 TSH Receptor Monoclonal Antibody (49) Catalog Number MA3-218 Product data sheet Details

More information

Double-Stranded Ribonucleic Acid into Virus Corelike Particles

Double-Stranded Ribonucleic Acid into Virus Corelike Particles JOURNAL OF VIROLOGY, Nov. 197, p. 943-95 Copyright 197 American Society for Microbiology Vol. 1, No. 5 Printed in U.S.A. Incorporation of In Vitro Synthesized Reovirus Double-Stranded Ribonucleic Acid

More information

ab Membrane Fractionation Kit Instructions for Use For the rapid and simple separation of membrane, cytosolic and nuclear cellular fractions.

ab Membrane Fractionation Kit Instructions for Use For the rapid and simple separation of membrane, cytosolic and nuclear cellular fractions. ab139409 Membrane Fractionation Kit Instructions for Use For the rapid and simple separation of membrane, cytosolic and nuclear cellular fractions. This product is for research use only and is not intended

More information

SUPPLEMENTAL INFORMATION

SUPPLEMENTAL INFORMATION SUPPLEMENTAL INFORMATION EXPERIMENTAL PROCEDURES Tryptic digestion protection experiments - PCSK9 with Ab-3D5 (1:1 molar ratio) in 50 mm Tris, ph 8.0, 150 mm NaCl was incubated overnight at 4 o C. The

More information

Chapter PURIFICATION OF ALKALINE PROTEASES

Chapter PURIFICATION OF ALKALINE PROTEASES Chapter PURIFICATION OF ALKALINE PROTEASES E /xtracellular alkaline proteases produced by Bacillus sp. K 25 and bacillus pumilus K 242, were purified and the homogeneity was examined by electrophoresis.

More information

Preparation and properties of a novel influenza subunit vaccine G. SCHMIDT* H. BACHMAYER E. LIEHL. guinea-pigs, s.c. and i.m. for rabbits.

Preparation and properties of a novel influenza subunit vaccine G. SCHMIDT* H. BACHMAYER E. LIEHL. guinea-pigs, s.c. and i.m. for rabbits. Postgraduate Medical Journal (June 1976), 52, 360-367. Preparation and properties of a novel influenza subunit vaccine H. BACHMAYER E. LIEHL Ph.D. Ph.D. G. SCHMIDT Ph.D. Summary Haemagglutinin and neuraminidase

More information

Objective 3. Develop new and improved diagnostic tools, vaccines, and novel management approaches

Objective 3. Develop new and improved diagnostic tools, vaccines, and novel management approaches Objective 3. Develop new and improved diagnostic tools, vaccines, and novel management approaches Development of novel nanoparticle-base vaccines for infectious bronchitis PI, Mazhar I. Khan; CoPI, Peter

More information

Infectious Bursal Disease, Immunosuppression and the role of VAXXITEK HVT+ IBD

Infectious Bursal Disease, Immunosuppression and the role of VAXXITEK HVT+ IBD Research note Infectious Bursal Disease, Immunosuppression and the role of VAXXITEK HVT+ IBD Grogan K. 1 1 Poultry Chicken Scratch, LLC, 30019 Dacula GA United States of America [from Hoerr F.J., 2010,

More information

Procine sphingomyelin ELISA Kit

Procine sphingomyelin ELISA Kit Procine sphingomyelin ELISA Kit For the quantitative in vitro determination of Procine sphingomyelin concentrations in serum - plasma - celiac fluid - tissue homogenate - body fluid FOR LABORATORY RESEARCH

More information

Comparison of Swine Vesicular Disease Virus and Coxsackie B5 Virus by Serological and RNA Hybridization Methods

Comparison of Swine Vesicular Disease Virus and Coxsackie B5 Virus by Serological and RNA Hybridization Methods J. gen. Virol. (I976), 31, 231-237 Printed in Great Britain 23I Comparison of Swine Vesicular Disease Virus and Coxsackie B5 Virus by Serological and RNA Hybridization Methods By F. BROWN, T. F. WILD,

More information

Isolation and identification of Mycoplasma gallisepticum in chickensbn from industrial farms in Kerman province

Isolation and identification of Mycoplasma gallisepticum in chickensbn from industrial farms in Kerman province Available online at http://www.ijabbr.com International journal of Advanced Biological and Biomedical Research Volume 2, Issue 1, 2014: 100-104 Isolation and identification of Mycoplasma gallisepticum

More information

Animal model for testing human Ascaris allergens

Animal model for testing human Ascaris allergens J. Biosci., Vol. 3 Number 1, March 1981, pp. 77-82. Printed in India. Animal model for testing human Ascaris allergens KRISHNA MUKERJI*, R. P. SAXENA, S. N. GHATAK and K. C. SAXENA Division of Biochemistry,

More information

Norgen s HIV proviral DNA PCR Kit was developed and validated to be used with the following PCR instruments: Qiagen Rotor-Gene Q BioRad icycler

Norgen s HIV proviral DNA PCR Kit was developed and validated to be used with the following PCR instruments: Qiagen Rotor-Gene Q BioRad icycler 3430 Schmon Parkway Thorold, ON, Canada L2V 4Y6 Phone: (905) 227-8848 Fax: (905) 227-1061 Email: techsupport@norgenbiotek.com HIV Proviral DNA PCR Kit Product # 33840 Product Insert Background Information

More information

Item Catalog Number Manufacturer 1,4-Dithioerythritol (1 g) D9680 Sigma-Aldrich

Item Catalog Number Manufacturer 1,4-Dithioerythritol (1 g) D9680 Sigma-Aldrich SOP: Nuclei isolation from fresh mouse tissues and DNaseI treatment Date modified: 01/12/2011 Modified by: E. Giste/ T. Canfield (UW) The following protocol describes the isolation of nuclei and subsequent

More information

Coronaviruses cause acute, mild upper respiratory infection (common cold).

Coronaviruses cause acute, mild upper respiratory infection (common cold). Coronaviruses David A. J. Tyrrell Steven H. Myint GENERAL CONCEPTS Clinical Presentation Coronaviruses cause acute, mild upper respiratory infection (common cold). Structure Spherical or pleomorphic enveloped

More information

Influenza A H1N1 (Swine Flu 2009) Hemagglutinin / HA ELISA Pair Set

Influenza A H1N1 (Swine Flu 2009) Hemagglutinin / HA ELISA Pair Set Influenza A H1N1 (Swine Flu 2009) Hemagglutinin / HA ELISA Pair Set Catalog Number : SEK001 To achieve the best assay results, this manual must be read carefully before using this product and the assay

More information

A Single-Radial-lmmunodiffusion Technique for the Assay of Rabies Glycoprotein Antigen: Application for Potency Tests of Vaccines Against Rabies

A Single-Radial-lmmunodiffusion Technique for the Assay of Rabies Glycoprotein Antigen: Application for Potency Tests of Vaccines Against Rabies J. gen. Virol. (1982) 59, 197-201. Printed in Great Britain 197 Key words: rabies/glycoprotein/immunodiffusion/vaccine potency A Single-Radial-lmmunodiffusion Technique for the Assay of Rabies Glycoprotein

More information

antigen Y. Kajita, D. Morgan, A.B. Parkes and B. Rees Smith

antigen Y. Kajita, D. Morgan, A.B. Parkes and B. Rees Smith Volume 87, number 2 FEBS 2756 August 985 Labelling and immunoprecipitation antigen of thyroid microsomal Y. Kajita, D. Morgan, A.B. Parkes and B. Rees Smith Endocrine Immunology Unit, 7th Floor Medicine.

More information

making LT protection safer and easier

making LT protection safer and easier making LT protection safer and easier 1 vaccine up to 3 immunities 4 Vectormune FP-LT and. Vectormune FP-LT is a genetically engineered live fowl pox virus vaccine carrying 2 immunorelevant genes from

More information

Rubella Latex Agglutination Test

Rubella Latex Agglutination Test Rubella Latex Agglutination Test Cat. No.:DLAT1088 Pkg.Size:30T Intended use The Rubella Latex Agglutination Test is a rapid latex particle agglutination test for the qualitative and semi-quantitative

More information

Response of the Embryo to in ovo

Response of the Embryo to in ovo Response of the Embryo to in ovo Vaccination with IBDV Jagdev Sharma a The Biodesign Institute Arizona State University Tempe, Arizona, U.S.A. BUDAPEST 37 Billion chickens produced yearly y IBDV A highly

More information

ISOLATION OF A SARCOMA VIRUS FROM A SPONTANEOUS CHICKEN TUMOR

ISOLATION OF A SARCOMA VIRUS FROM A SPONTANEOUS CHICKEN TUMOR ISOLATION OF A SARCOMA VIRUS FROM A SPONTANEOUS CHICKEN TUMOR Shigeyoshi ITOHARA, Kouichi HIRATA, Makoto INOUE, Masanori Veterinary Pathology, Faculty of Agriculture, Yamaguchi University* HATSUOKA, and

More information

PRODUCT: RNAzol BD for Blood May 2014 Catalog No: RB 192 Storage: Store at room temperature

PRODUCT: RNAzol BD for Blood May 2014 Catalog No: RB 192 Storage: Store at room temperature PRODUCT: RNAzol BD for Blood May 2014 Catalog No: RB 192 Storage: Store at room temperature PRODUCT DESCRIPTION. RNAzol BD is a reagent for isolation of total RNA from whole blood, plasma or serum of human

More information

Determinants of the Host Range of Feline Leukaemia Viruses

Determinants of the Host Range of Feline Leukaemia Viruses J. gen. Virol. (1973), 20, I69-t75 Printed in Great Britain 169 Determinants of the Host Range of Feline Leukaemia Viruses By O. JARRETT, HELEN M. LAIRD AND D. HAY University of Glasgow, Leukaemia Research

More information